Ronald Anderson Selected Research

Biomarkers (Surrogate Marker)

1/2023	Comparison of platelet-and endothelial-associated biomarkers of disease activity in people hospitalized with Covid-19 with and without HIV co-infection.
1/2022	Elevated Levels of Soluble CTLA-4, PD-1, PD-L1, LAG-3 and TIM-3 and Systemic Inflammatory Stress as Potential Contributors to Immune Suppression and Generalized Tumorigenesis in a Cohort of South African Xeroderma Pigmentosum Patients.
1/2020	Differential Responsiveness of the Platelet Biomarkers, Systemic CD40 Ligand, CD62P, and Platelet-Derived Growth Factor-BB, to Virally-Suppressive Antiretroviral Therapy.
2/2019	Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy.
1/2019	Interleukin-10 and interleukin-1 receptor antagonist distinguish between patients with sepsis and the systemic inflammatory response syndrome (SIRS).
1/2018	Effects of Tobacco Usage and Antiretroviral Therapy on Biomarkers of Systemic Immune Activation in HIV-Infected Participants.
6/2017	Effect of smoking on acute phase reactants, stress hormone responses and vitamin C in pulmonary tuberculosis.
10/2016	Fatty acid-binding proteins as biomarkers of disease severity and outcome in community-acquired pneumonia.
6/2016	Reliable and cost-effective serodiagnosis of rheumatoid arthritis.
5/2015	Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ronald Anderson Research Topics

Disease

24	Neoplasms (Cancer) 05/2024 - 01/2008
21	Infections 02/2024 - 05/2005
19	Inflammation (Inflammations) 01/2023 - 08/2003
17	Pneumococcal Infections 07/2023 - 06/2002
16	Pneumonia (Pneumonitis) 07/2023 - 10/2006
10	Rheumatoid Arthritis 01/2019 - 01/2010
7	HIV Infections (HIV Infection) 01/2023 - 01/2011
6	Neutropenia 02/2024 - 11/2020
4	Tuberculosis (Tuberculoses) 01/2022 - 02/2013
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 08/2015
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 12/2010
3	Septic Shock (Toxic Shock Syndrome) 11/2023 - 01/2020
3	Sepsis (Septicemia) 06/2022 - 01/2019
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020 - 02/2012
3	Asthma (Bronchial Asthma) 01/2013 - 05/2005
2	Febrile Neutropenia 10/2023 - 03/2021
2	Disease Progression 07/2023 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2022
2	Coinfection 01/2023 - 04/2021
2	Shock 06/2022 - 01/2020
2	Critical Illness (Critically Ill) 06/2022 - 01/2020
2	Hypoaldosteronism (Hyporeninemic Hypoaldosteronism) 06/2022 - 01/2020
2	Hematologic Neoplasms (Hematological Malignancy) 03/2021 - 12/2018
2	Enterocolitis 12/2020 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2020 - 01/2019
2	Cardiotoxicity 01/2020 - 01/2018
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2020 - 01/2017
2	Pulmonary Tuberculosis 01/2019 - 06/2017
2	Leukemia 12/2018 - 04/2010
2	Genetic Predisposition to Disease (Genetic Predisposition) 06/2018 - 01/2013
2	Pneumococcal Pneumonia 01/2011 - 04/2009
2	Hodgkin Disease (Hodgkin's Disease) 03/2010 - 03/2010
2	Chronic Granulomatous Disease 11/2004 - 06/2004
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 10/2023
1	Lung Neoplasms (Lung Cancer) 07/2023
1	Thrombosis (Thrombus) 07/2023
1	COVID-19 01/2023
1	Obesity 12/2022
1	Insulin Resistance 12/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2022
1	Weight Gain 12/2022
1	Hyperaldosteronism (Conn Syndrome) 06/2022
1	Hemorrhagic Shock 06/2022

Drug/Important Bio-Agent (IBA)

13	Anti-Bacterial Agents (Antibiotics)IBA 07/2023 - 05/2005
12	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2013
12	CytokinesIBA 01/2022 - 04/2007
10	Streptococcus pneumoniae plY proteinIBA 07/2023 - 06/2002
9	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
7	MacrolidesIBA 07/2023 - 08/2003
7	Virulence Factors (Pathogenicity Factors)IBA 01/2020 - 08/2003
6	VaccinesIBA 07/2023 - 06/2002
6	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022 - 08/2003
5	ChemokinesIBA 01/2022 - 06/2016
5	Acute-Phase Proteins (Acute-Phase Protein)IBA 06/2017 - 01/2010
4	Clofazimine (Lamprene)FDA Link 01/2022 - 02/2012
4	Conjugate VaccinesIBA 01/2020 - 08/2003
4	Anti-Citrullinated Protein AntibodiesIBA 06/2018 - 06/2010
3	GlucocorticoidsIBA 11/2023 - 01/2020
3	FludrocortisoneIBA 11/2023 - 01/2020
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2023 - 11/2020
3	Chemokine CCL5IBA 01/2022 - 01/2018
3	NivolumabIBA 01/2021 - 01/2019
3	SmokeIBA 01/2019 - 01/2011
3	AutoantibodiesIBA 06/2018 - 01/2010
3	Rheumatoid FactorIBA 06/2018 - 06/2010
3	Anti-Infective Agents (Microbicides)IBA 03/2015 - 10/2006
2	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2023 - 06/2022
2	Oxygen (Dioxygen)IBA 01/2023 - 01/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2008
2	Polysaccharides (Glycans)IBA 09/2022 - 08/2003
2	Penicillins (Penicillin)FDA Link 09/2022 - 01/2019
2	Angiotensin IIIBA 06/2022 - 01/2020
2	ReninIBA 06/2022 - 01/2020
2	MineralocorticoidsIBA 06/2022 - 01/2020
2	Immune Checkpoint ProteinsIBA 05/2022 - 01/2022
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 01/2021
2	AntigensIBA 01/2021 - 01/2011
2	pembrolizumabIBA 01/2021 - 01/2019
2	AntibodiesIBA 12/2020 - 06/2018
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 03/2009
2	Antirheumatic Agents (DMARD)IBA 01/2019 - 05/2015
2	Peptides (Polypeptides)IBA 06/2018 - 08/2003
2	NADPH Oxidases (NAD(P)H oxidase)IBA 11/2004 - 06/2004
1	Filgrastim (Neupogen)FDA Link 02/2024
1	Tobacco Smoke Pollution (Passive Smoking)IBA 02/2024
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2023
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2023
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 07/2023
1	dolutegravirIBA 12/2022
1	HIV IntegraseIBA 12/2022
1	AldosteroneIBA 06/2022

Therapy/Procedure

34	Therapeutics 05/2024 - 05/2005
11	Drug Therapy (Chemotherapy) 02/2024 - 05/2005
9	Immunotherapy 01/2023 - 01/2018
6	Highly Active Antiretroviral Therapy (HAART) 01/2020 - 01/2014
2	Radiotherapy 01/2021 - 02/2019
2	Critical Care (Surgical Intensive Care) 03/2016 - 08/2015
1	Hematopoietic Stem Cell Mobilization 02/2024
1	Length of Stay 01/2023
1	Neoadjuvant Therapy 01/2023